HBIO (STOCKS)
Harvard Bioscience Inc
$0.580700
+0.036900 (+6.79%)
Prev close: $0.543800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John D. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.25M
- Employees
- 355
- P/E (TTM)
- -0.46
- P/B (TTM)
- 1.72
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.00 | $0.01 | -0.0051 | -100.00% |
|
Jun 2025 (Q2)
|
$-0.01 | $-0.01 | +0.0002 | +1.96% |
|
Mar 2025 (Q1)
|
$-0.01 | $-0.04 | +0.0308 | +75.49% |
|
Dec 2024 (Q4)
|
$0.06 | $0.05 | +0.0090 | +17.65% |
Financial Statements
| Revenues | $87.37M |
| Benefits Costs and Expenses | $140.96M |
| Cost Of Revenue | $37.62M |
| Costs And Expenses | $140.96M |
| Gross Profit | $49.75M |
| Nonoperating Income/Loss | -$3.31M |
| Operating Expenses | $100.03M |
| Research and Development | $8.97M |
| Other Operating Expenses | $91.06M |
| Operating Income/Loss | -$50.28M |
| Income/Loss From Continuing Operations After Tax | -$53.84M |
| Income/Loss From Continuing Operations Before Tax | -$53.59M |
| Income Tax Expense/Benefit | $243.00K |
| Net Income/Loss | -$53.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$53.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$53.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.21 |
| Diluted Earnings Per Share | -$1.21 |
| Basic Average Shares | 44,359,000 |
| Diluted Average Shares | 44,359,000 |
| Assets | $77.99M |
| Current Assets | $43.81M |
| Inventory | $21.60M |
| Other Current Assets | $22.20M |
| Noncurrent Assets | $34.19M |
| Fixed Assets | $4.99M |
| Intangible Assets | $8.38M |
| Other Non-current Assets | $20.82M |
| Liabilities | $63.92M |
| Current Liabilities | $54.40M |
| Accounts Payable | $5.18M |
| Wages | $1.87M |
| Other Current Liabilities | $47.35M |
| Noncurrent Liabilities | $9.53M |
| Long-term Debt | $34.00M |
| Equity | $14.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.07M |
| Liabilities And Equity | $77.99M |
| Net Cash Flow From Operating Activities | $8.55M |
| Net Cash Flow From Operating Activities, Continuing | $8.55M |
| Net Cash Flow From Investing Activities | -$1.73M |
| Net Cash Flow From Investing Activities, Continuing | -$1.73M |
| Net Cash Flow From Financing Activities | -$5.10M |
| Net Cash Flow From Financing Activities, Continuing | -$5.10M |
| Net Cash Flow | $1.72M |
| Net Cash Flow, Continuing | $1.72M |
| Comprehensive Income/Loss | -$53.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$53.21M |
| Other Comprehensive Income/Loss | $622.00K |